Norvasc: Effective Blood Pressure Control with Amlodipine
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.00 (0%) | 🛒 Add to cart |
| 90 | $0.66 | $64.50 $59.34 (8%) | 🛒 Add to cart |
| 120 | $0.62 | $86.00 $74.82 (13%) | 🛒 Add to cart |
| 180 | $0.59 | $129.00 $105.78 (18%) | 🛒 Add to cart |
| 270 | $0.56 | $193.50 $152.22 (21%) | 🛒 Add to cart |
| 360 | $0.55
Best per pill | $258.00 $199.52 (23%) | 🛒 Add to cart |
| Product dosage: 2.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.29 | $52.46 (0%) | 🛒 Add to cart |
| 270 | $0.27 | $78.69 $73.10 (7%) | 🛒 Add to cart |
| 360 | $0.26
Best per pill | $104.92 $93.74 (11%) | 🛒 Add to cart |
Norvasc (amlodipine besylate) is a first-line calcium channel blocker prescription medication indicated for the management of hypertension and chronic stable angina. Developed and manufactured under stringent pharmaceutical standards, it functions by relaxing and widening blood vessels, allowing blood to flow more easily and reducing the cardiac workload. This medication is renowned for its long half-life, which supports consistent 24-hour blood pressure control with once-daily dosing, promoting patient adherence and therapeutic stability. It is suitable for long-term use in appropriate patient populations and is often utilized both as monotherapy and in combination with other antihypertensive agents.
Features
- Active ingredient: Amlodipine besylate
- Available in tablet strengths: 2.5 mg, 5 mg, and 10 mg
- Class: Dihydropyridine calcium channel blocker (CCB)
- Administration: Oral, once daily
- Long plasma half-life (~30–50 hours) supports steady-state concentration
- FDA-approved for hypertension and chronic stable angina
- Available as both brand-name and generic formulations
Benefits
- Provides consistent 24-hour blood pressure reduction with a single daily dose
- Reduces frequency of angina episodes and need for nitroglycerin use
- Lowers risk of cardiovascular events associated with uncontrolled hypertension
- Generally well-tolerated with a favorable side effect profile compared to other antihypertensives
- Suitable for use in a wide range of patient demographics, including elderly populations
- Can be effectively combined with other antihypertensive classes for synergistic effects
Common use
Norvasc is primarily prescribed for the treatment of hypertension, either as monotherapy or in combination with other blood pressure-lowering agents such as ACE inhibitors, angiotensin II receptor blockers, or diuretics. It is also indicated for the management of chronic stable angina, where it helps reduce myocardial oxygen demand by decreasing peripheral vascular resistance and afterload. In clinical practice, it may be used off-label for certain cases of Raynaud’s phenomenon or in specific hypertensive urgencies under medical supervision.
Dosage and direction
The recommended initial dose for hypertension in adults is 5 mg taken orally once daily. The dosage may be increased to a maximum of 10 mg once daily based on individual patient response and tolerability. For angina, the starting dose is typically 5–10 mg once daily. In elderly patients or those with hepatic impairment, a lower initial dose of 2.5 mg daily is advised. Norvasc may be taken with or without food. Consistency in dosing time is recommended to maintain stable plasma levels. Dosage adjustments should be made under clinical supervision at intervals of 7–14 days.
Precautions
Patients should be monitored for signs of hypotension, especially during initial titration or when used concomitantly with other antihypertensives. Use with caution in patients with severe aortic stenosis, heart failure, or hepatic impairment. Peripheral edema is a common side effect and may be dose-dependent. Abrupt discontinuation is not recommended; gradual tapering under medical guidance is advised if cessation is necessary. Patients should avoid grapefruit juice, as it may increase amlodipine plasma concentrations.
Contraindications
Norvasc is contraindicated in patients with known hypersensitivity to amlodipine or any component of the formulation. It should not be used in cases of severe hypotension or cardiogenic shock. Use is also contraindicated in patients with obstructive cardiomyopathy where vasodilation may exacerbate the condition.
Possible side effect
Common side effects include peripheral edema, dizziness, flushing, palpitations, and headache. Less frequently, patients may experience nausea, abdominal pain, fatigue, or somnolence. Rare but serious adverse effects include symptomatic hypotension, worsening angina or acute myocardial infarction (particularly at initiation), and severe peripheral edema. Allergic reactions such as rash, pruritus, or angioedema may occur in susceptible individuals.
Drug interaction
Norvasc may interact with other antihypertensive agents, potentiating hypotensive effects. Concurrent use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase amlodipine levels. Simvastatin co-administration should be monitored due to potential increased simvastatin exposure. Use with sildenafil or other phosphodiesterase inhibitors may enhance hypotensive effects. Calcium supplements may reduce the efficacy of calcium channel blockers.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is nearly time for the next dose, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to compensate for a missed dose is not recommended.
Overdose
Overdose may lead to pronounced hypotension and reflex tachycardia. In cases of suspected overdose, symptomatic and supportive measures should be initiated, including cardiovascular monitoring and elevation of extremities. IV calcium gluconate may be considered in severe cases. Hemodialysis is not effective due to high protein binding.
Storage
Store at room temperature (20–25°C or 68–77°F) in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Individual patient responses may vary.
Reviews
Clinical studies and post-marketing surveillance indicate that Norvasc is effective and generally well-tolerated. Many patients report significant improvements in blood pressure control and reduced angina symptoms. Some users note peripheral edema as a limiting factor, though it is often manageable with dose adjustment or combination therapy. Overall, it remains a widely trusted option in cardiovascular pharmacotherapy.